Moreover, MYC is an essential NOTCH1 target for tumour progression in mammalian T cell lymphoblastic leukaemia (T-ALL) cells [99] and mouse models [100,101], where the Myc promoter is directly activated as a result of binding by intracellular domain of NOTCH and CBF1. Here, MYC is linked to acute lymphoblastic leukemia.